Navigation Links
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
Date:5/29/2009

response rate at 16-weeks (for part 2) was 63 percent (80 percent CI, 55.9 percent to 69.4).

In this preliminary analysis, the adverse event profile of the combination of neratinib (240 mg) plus paclitaxel (80 mg/m2) was similar to that reported with both agents as monotherapy. Adverse events of any grade were diarrhea, alopecia, infection, peripheral neuropathy, leucopenia, anemia, nausea, rash, fatigue and vomiting. The most common adverse event was diarrhea, observed in 89 percent of the 102 patients enrolled in part 2 and was the most significant grade 3 or 4 adverse event, occurring in 25 percent of patients. Fourteen patients had dose reductions and one patient withdrew from the study due to an adverse event.

"Emerging clinical data continue to suggest that neratinib, in combination with these therapies is tolerable and active in treating HER-2 positive disease, even in those women who have progressed while on other targeted therapies," says Gary L. Stiles, M.D., Chief Medical Officer, Wyeth Pharmaceuticals. "These additional data build upon results presented at the 2008 San Antonio Breast Cancer Symposium, and Wyeth is committed to evaluating further the potential of this investigational therapy."

In 2008, the American Cancer Society estimated that more than 182,000 women in the United States would be diagnosed with breast cancer, and more than 40,000 would die from the disease. The HER-2 receptor is over-expressed in 25 percent to 30 percent of patients with breast cancer.

About Wyeth

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyet
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. TargeGen Announces Successful Completion of Patient Enrollment in Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients and Scheduled Presentation of Preliminary Trial Data at EHA Conference in Berlin
2. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
3. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
4. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
5. Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
6. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
7. Neuronetrix Announces Preliminary Alzheimers Study Results at the Society for Neuroscience Conference
8. CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
9. Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa
10. What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study
11. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Needle-Free Delivery: Technology ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html Report Details ... commercial prospects What does the future hold ... new report shows you the potential revenues ...
(Date:8/28/2014)... , Aug. 28, 2014  Decision Resources Group ... will grow strongly through 2022 at a compound ... will be largely supported by strong population growth ... demand for imaging procedures. The Indian government,s greater ... facilities to purchase or upgrade diagnostic imaging equipment. ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- EDGE Orthopaedics, ... space, is excited to announce they have received ... Plating System and REDUCE Fracture Plating System. ... used to support multiple indications within the mid-foot. ... First Metatarsophalangeal (MTP), Calcaneal-Cuboid (CC), Talonavicular (TN) and ...
Breaking Medicine Technology:Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3EDGE Orthopaedics Receives Second FDA Clearance 2
... NEW YORK, Aug. 25 Reportlinker.com ... report is available in its catalogue: ... the Asia-Pacific Region – India and ... still dominates high value transactions ...
... (Nasdaq: BIOD ) today announced that it has ... 2,398,200 shares of its common stock and warrants to purchase ... warrants are being sold as units, with each unit consisting ... purchase one share of common stock.   The ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 2Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 3Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 4Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 5Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 6Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 7Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 8Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 9Biodel to Raise $9.4 Million Through Registered Direct Offering 2Biodel to Raise $9.4 Million Through Registered Direct Offering 3
(Date:8/29/2014)... (PRWEB) August 29, 2014 As a ... City, Fla., understands that there’s a direct connection between ... knees, hips and back. "Since conventional shoe inserts and ... a solution of my own," he said. , Customizable ... provides better support for the foot in order to ...
(Date:8/29/2014)... 29, 2014 Glendale Botox experts ... on Botox throughout the month of September. This special offer ... two syringes of Juvederm. Patients can take advantage of this ... The Glendale Botox experts will work with patients to determine ... What is Botox? , Botox is a treatment ...
(Date:8/29/2014)... (HealthDay News) -- The main strain of a ... and North Africa originated in sub-Saharan Africa, a ... methicillin-resistant Staphylococcus aureus (CA-MRSA) infections, which ... been hospitalized. These infections typically affect the skin ... through touching contaminated objects such as clothing or ...
(Date:8/29/2014)... 2014 (HealthDay News) -- The way that parents respond ... development, a new study suggests. Over six months, ... infants during free play. The sessions were 30 minutes ... 8 months old at the start of the study. ... babbling, infants began to form complex sounds. The babies ...
(Date:8/29/2014)... August 29, 2014 For the fifth ... (Meso Foundation) will be observing September 26th as Mesothelioma ... Plaza, in New York. , Members of the ... RSVP . The Foundation will be providing t-shirts and ... years, mesothelioma community members have received attention from ...
Breaking Medicine News(10 mins):Health News:Glenoaks Laser Center is Now Offering a Special Promotion on Botox for the Month of September 2Health News: European MRSA Originated in Sub-Saharan Africa, Study Finds 2Health News:Encouraging Your Baby's Babbling May Speed Language Development 2Health News:Organization to Raise Awareness of Mesothelioma on the Today Show 2
... mental function, study says , , THURSDAY, June 12 ... to fight cancer may reduce disease activity and disability ... small trial suggest. , In relapsing-remitting MS, the ... of symptoms followed by stretches of symptom-free remission when ...
... 12 Cancer Clinics of Excellence (CCE), the,nation,s ... has announced its management slate and Board of ... CCE. Most,recently, he was the interim President of ... Group was named Chief Medical,Officer. Dr. Bosserman had ...
... 12 Do you know a,Champion?, The ... working to improve Oklahoma,s health. The 2008 Champions ... are making a,significant difference in the health of ... Friday, Aug. 1., Nominations can be submitted ...
... June 12 The Arizona Board of Regents,recently ... of Arizona,College of Medicine Program in Integrative Medicine ... medicine has had on health-care,system transformation., Now ... (AzCIM), the,program underwent an intensive evaluation process and ...
... performance and lifestyle brand is paired with LensCrafters, ... 500 North American stores, MASON, Ohio, June ... at more than 500 select LensCrafters locations, North ... customers the,combined benefits of Oakley,s popular and innovative ...
... to call, write letters to Schwarzenegger,expressing their outrage, ... of home healthcare workers will rally to protest ... service, wages and,benefits. These dramatic reductions would force ... they serve deeper into poverty. It also,will force ...
Cached Medicine News:Health News:Cancer Drug Appears to Help With Aggressive MS 2Health News:Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting 2Health News:Nominations Accepted for 2008 'Champions of Health' Awards 2Health News:The University of Arizona Program in Integrative Medicine Earns 'Center of Excellence' Designation 2Health News:The University of Arizona Program in Integrative Medicine Earns 'Center of Excellence' Designation 3Health News:Oakley Prescription Eyewear Now at Lenscrafters 2Health News:Oakley Prescription Eyewear Now at Lenscrafters 3Health News:Oakley Prescription Eyewear Now at Lenscrafters 4
... eye-nasal. High volume/low pressure cuff. X-ray ... surgical access. Designed to reduce kinking ... preformed curvature. Thin-walled, large volume low-pressure ... the anatomical situation at body temperature. ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua...
... For Laryngotracheal Instillation of Topical Anesthetic, ... populations, this cuffed tube incorporates an ... spray application of topical anesthetic above ... offers three endotracheal tubes designs which ...
Medicine Products: